Literature DB >> 20493667

The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.

Y Simchon1, A Weizman, M Rehavi.   

Abstract

Dysregulations in monoaminergic systems have been implicated in attention deficit/hyperactivity disorder. The spontaneous hypertensive rats (SHR) are used as an animal model for ADHD. Juvenile SHR rats exhibited low dopamine transporter (DAT) density, low vesicular monoamine transporter 2 (VMAT2) density and lower unstimulated dopamine (DA) release in comparison to their corresponding WKY controls. Chronic methylphenidate treatment of the young SHR rats was associated with lower DAT density and lower unstimulated basal dopamine release but with enhanced potassium- and amphetamine-induced dopamine release. These neurochemical alterations might be relevant to the pathophysiology and to the beneficial effect of methylphenidate in ADHD. Copyright 2010 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493667     DOI: 10.1016/j.euroneuro.2010.04.007

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  9 in total

1.  Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD).

Authors:  Mircea I Chelaru; Pamela B Yang; Nachum Dafny
Journal:  Behav Brain Res       Date:  2011-08-25       Impact factor: 3.332

2.  The effects of rearing environment and chronic methylphenidate administration on behavior and dopamine receptors in adolescent rats.

Authors:  Kathryn E Gill; Thomas J R Beveridge; Hilary R Smith; Linda J Porrino
Journal:  Brain Res       Date:  2013-06-24       Impact factor: 3.252

3.  Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.

Authors:  Kathryn E Gill; Peter J Pierre; James Daunais; Allyson J Bennett; Susan Martelle; H Donald Gage; James M Swanson; Michael A Nader; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2012-07-18       Impact factor: 7.853

4.  Effects of Methylphenidate on the Dopamine Transporter and Beyond.

Authors:  Tyra S C Zetterström; Emmanuel Quansah; Martin Grootveld
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins.

Authors:  Yaarit Simchon Tenenbaum; Abraham Weizman; Moshe Rehavi
Journal:  J Mol Neurosci       Date:  2015-07-08       Impact factor: 3.444

6.  The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Vivienne A Russell; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropharmacology       Date:  2012-09-01       Impact factor: 5.250

7.  Baicalin regulates the dopamine system to control the core symptoms of ADHD.

Authors:  Rongyi Zhou; Jiaojiao Wang; Xinmin Han; Bingxiang Ma; Haixia Yuan; Yuchen Song
Journal:  Mol Brain       Date:  2019-02-08       Impact factor: 4.041

8.  Marine Ο-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD.

Authors:  Kine S Dervola; Bjørg A Roberg; Grete Wøien; Inger Lise Bogen; Torbjørn H Sandvik; Terje Sagvolden; Christian A Drevon; Espen Borgå Johansen; Sven Ivar Walaas
Journal:  Behav Brain Funct       Date:  2012-12-10       Impact factor: 3.759

9.  Long Withdrawal of Methylphenidate Induces a Differential Response of the Dopaminergic System and Increases Sensitivity to Cocaine in the Prefrontal Cortex of Spontaneously Hypertensive Rats.

Authors:  Maurício dos Santos Pereira; Matheus Figueiredo Sathler; Thais da Rosa Valli; Richard Souza Marques; Ana Lucia Marques Ventura; Ney Ronner Peccinalli; Mabel Carneiro Fraga; Alex C Manhães; Regina Kubrusly
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.